Skip to main content
. 2022 Dec 26;13(1):43. doi: 10.3390/biom13010043

Figure 7.

Figure 7

RAB42 was a predictor for immunotherapy. (A) Spearman’s correlation between RAB42 and immune checkpoint genes expression in the ACLBI database. (B) Differences in RAB42 expression among responders and non-responders treated with PD1/PD-L1 inhibitors using the TISIDB database. (C) The effect of RAB42 expression on the prognosis of melanoma patients treated with PD1 or CTLA4 inhibitors using the TIDE database. (D) Predictive value of RAB42 for immunotherapy using the TIDE database. * p < 0.05; ** p < 0.01.